Monthly Archives: November 2012

Pharma Forecast 2020: Cold Comfort

Price Waterhouse Cooper’s “Pharma 2020: From vision to decision” parses a mix of gloomy and glowing scenarios that reflect the fickle, delicate nature of today’s industry. On the one hand, innovations in other areas such as mobile technology promise to breathe new life into pharma with cutting-edge initiatives. On the opposite end, stark fiscal realities […]
Posted in compliance, Emerging Markets, Europe, FDA, Global, IP, pricing, R&D, Regulatory, Strategy | Leave a comment

Hepatitis C: Engaging Patients Online

Given the amount of activity in the hepatitis C drug development space – as evidenced in PharmExec’s 2013 Pipeline report – patients are scouring the internet for information on the disease, available treatments, and soon to be available treatments. A new Industry Standard Research report examines the digital cracks consumers encounter when looking for information […]
Posted in Advertising, E-Media, Marketing, multimedia, patient education, social media, Strategy | Tagged , , , , , , , | Leave a comment

Pharma in the Dell: Working with Academia

How can the emerging field of data science help to fruitfully translate research and discovery into successful drug development? Academics and pharmaceutical executives at Mount Sinai’s School of Medicine discussed ways to build a bridge across the valley of death, and the growing importance of data across all business areas.
Posted in Biotech, Deals, IP, leadership, Meetings, People, R&D, Strategy, Technology | Tagged , , , , , , | Leave a comment

Dissecting ACA's Section 6004: Tipping the Balance on Sampling Controls?

With the Affordable Care Act [ACA] officially settling into the US’ political landscape, a pressing – but little noticed – issue is the provisions for increased compliance on industry promotion practices.  Of specific concern is Section 6004 of the ACA, which demands more rigorous reporting on the distribution of free samples to physicians from pharmaceutical […]
Posted in compliance, FDA, Manufacturing, Regulatory | 1 Comment

Pipeline Report Preview

Posted in Advertising, Biotech, Europe, FDA, Gene therapy, Global, IP, R&D, Regulatory, Strategy, Video | Tagged , , , , , , , , , | Leave a comment
  • Categories

  • Meta